A double-blind, placebo-controlled, multicenter study to examine the effects of finasteride 1 mg on serum prostate-specific antigen in men with androgenetic alopecia

Trial Profile

A double-blind, placebo-controlled, multicenter study to examine the effects of finasteride 1 mg on serum prostate-specific antigen in men with androgenetic alopecia

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2007

At a glance

  • Drugs Finasteride (Primary)
  • Indications Male pattern baldness
  • Focus Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 08 Jan 2007 Results have been published.
    • 21 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top